医学
糖肽
流行病学
革兰氏阳性细菌感染
抗性(生态学)
微生物学
计算生物学
重症监护医学
内科学
抗生素
生物
生态学
作者
Ali Zirakzadeh,Robin Patel
标识
DOI:10.1097/01.qco.0000186849.54040.2a
摘要
This review updates epidemiologic trends and our understanding of glycopeptide resistance in enterococci.Colonization and infection rates with vancomycin resistant enterococci continue to increase throughout the world while factors contributing to this rise continue to be defined. While no interventions exist to eradicate colonization, infection control procedures are cost effective and decrease the prevalence of vancomycin resistant enterococcal colonization and infection. New molecular methods show great promise in strengthening our ability to detect colonization with these bacteria. Furthermore, our understanding of the origin of vancomycin resistant enterococci continues to grow. Paenibacillus species found in soil have been found to carry homologues of vanA-associated glycopeptide resistance genes found in enterococci. Also, additional evidence supports previous data that VanB-associated resistance may have been horizontally transferred from gastrointestinal tract bacteria to enterococci. Finally, glycopeptide resistance has been transferred to methicillin-resistant Staphylococcus aureus in clinical practice on several occasions.The prevalence of vancomycin resistant enterococci will likely continue to increase. Implementation of infection control strategies, in conjunction with deployment of advanced technologies for detection of vancomycin resistant enterococci, may curb this rise. The emergence of vancomycin resistant S. aureus is of concern.
科研通智能强力驱动
Strongly Powered by AbleSci AI